Browsing Tag
dialysis treatment
2 posts
Unicycive (NASDAQ: UNCY) hit by FDA manufacturing concerns ahead of oxylanthanum carbonate decision
Unicycive’s NDA for oxylanthanum carbonate faces FDA manufacturing concerns. Key decision expected June 28. Read the stock outlook and next steps.
Amgen’s Parsabiv receives EC approval in secondary hyperparathyroidism
Amgen Inc., a leading American biopharmaceutical company, has achieved a significant milestone with the approval of its drug…